Chiralix enables flexible and efficient access to diversely substituted unique chiral building blocks for drug discovery, by integration of its proven top-notch technological capabilities in the areas of biocatalysis, homogeneous transition metal catalysis and organic synthesis.
This image is to illustrate the Chiralix company profile. From here you can view the profile or send an enquiry.
Copyright 2007SPG Media Limited a subsidiary of SPG Media Group PLC
